Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 study of ustekinumab in pediatric participants with Juvenile Psoriatic Arthritis or psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Psoriatic Arthritis
• Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Juvenile Psoriatic Arthritis, Psoriasis | Phase 1 | Status: COMPLETED